UNSPSC 51162335: Aspirin/promethazine/pseudoephedrine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

UNSPSC 51162335 Aspirin/promethazine/pseudoephedrine is a Commodity code that captures pharmaceutical products and related services purchased by state and local governments, though recent activity shows significant scope divergence from the code's nominal compound. The Washington State Department of Corrections RFQ RFQQK13020, posted September 8, 2026 with response due October 7, 2026, solicits parenteral products, services, and equipment—including intravenous solutions, parenteral nutrition preparations (TPN and PPN), and controlled substances for healthcare delivery to incarcerated individuals across eight correctional facilities. The scope includes compounding services, rapid delivery logistics (PN bags within 24 hours of order, other parenteral products within 8 hours), and patient monitoring coordination. A second, older opportunity from Seminole County, Florida (IFB60459723LAS, posted June 2026, due July 2023) sought naloxone and safe drug deactivation systems in large volumes (1,900 units of naloxone and 800 deactivation systems annually) for community health distribution. Issuing bodies span state corrections departments and county public health agencies; the Washington DOC RFQ encourages participation from small businesses (25% aspirational), minority-owned businesses (10%), women-owned businesses (6%), and veteran-owned businesses (5%), with Chapter 39.19 RCW compliance required for the contract.

Geographic activity centers on Washington State and Florida. The Washington DOC opportunity spans three geographic regions (West, Central, and East) with multiple facilities; DOC anticipates awarding up to three contractors per region for an initial term running November 26, 2026 through June 30, 2030. The Seminole County naloxone procurement targets quarterly deliveries to a single community health site in Sanford, Florida. The code shows limited recent alignment with aspirin/promethazine/pseudoephedrine formulations as named; recent state and local solicitations under this code emphasize parenteral compounding services and public health pharmaceuticals rather than the over-the-counter or standard-formulation products the code nominally describes.